OpenURL Connection Search

Select item for more details and to access through your institution.

Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
Published in:
1996
By:
- Tarnow L;
- Rossing P;
- Nielsen FS;
- Hansen BV;
- Dyerberg J;
- Parving HH;
- Tarnow, L;
- Rossing, P;
- Nielsen, F S;
- Hansen, B V;
- Dyerberg, J;
- Parving, H H
Publication type:
journal article
Low birth weight. A risk factor for development of diabetic nephropathy?
Published in:
1995
By:
- Rossing P;
- Tarnow L;
- Nielsen FS;
- Hansen BV;
- Brenner BM;
- Parving H;
- Rossing, P;
- Tarnow, L;
- Nielsen, F S;
- Hansen, B V;
- Brenner, B M;
- Parving, H H
Publication type:
journal article
Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes.
Published in:
2017
By:
- Østergaard, J.A.;
- Thiel, S.;
- Hoffmann‐Petersen, I.T.;
- Hovind, P.;
- Parving, H.‐H.;
- Tarnow, L.;
- Rossing, P.;
- Hansen, T.K.
Publication type:
journal article
Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.
Published in:
Diabetologia, 2009, v. 52, n. 1, p. 46, doi. 10.1007/s00125-008-1184-8
By:
- Schjoedt, K.;
- Astrup, A.;
- Persson, F.;
- Frandsen, E.;
- Boomsma, F.;
- Rossing, K.;
- Tarnow, L.;
- Rossing, P.;
- Parving, H.-H.
Publication type:
Article
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
Published in:
Diabetologia, 2008, v. 51, n. 11, p. 2100, doi. 10.1007/s00125-008-1123-8
By:
- Jorsal, A.;
- Tarnow, L.;
- Flyvbjerg, A.;
- Parving, H.-H.;
- Rossing, P.;
- Rasmussen, L.
Publication type:
Article
Long-term prevention of diabetic nephropathy: an audit.
Published in:
Diabetologia, 2008, v. 51, n. 6, p. 956, doi. 10.1007/s00125-008-0990-3
By:
- Schjoedt, K.;
- Hansen, H.;
- Tarnow, L.;
- Rossing, P.;
- Parving, H.-H.
Publication type:
Article
Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.
Published in:
Diabetologia, 2006, v. 49, n. 1, p. 11, doi. 10.1007/s00125-005-0077-3
By:
- Rossing, P.
Publication type:
Article
The changing epidemiology of diabetic microangiopathy in type 1 diabetes.
Published in:
Diabetologia, 2005, v. 48, n. 8, p. 1439, doi. 10.1007/s00125-005-1836-x
By:
- Rossing, P.
Publication type:
Article
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
Published in:
Diabetologia, 2004, v. 47, n. 11, p. 1936, doi. 10.1007/s00125-004-1542-0
By:
- Schjoedt, K.J.;
- Andersen, S.;
- Rossing, P.;
- Tarnow, L.;
- Parving, H.-H.
Publication type:
Article
Pregnancy and progression of diabetic nephropathy.
Published in:
Diabetologia, 2002, v. 45, n. 1, p. 36, doi. 10.1007/s125-002-8242-4
By:
- Rossing, K.;
- Jacobsen, P.;
- Hommel, E.;
- Mathiesen, E.;
- Svenningsen, A.;
- Rossing, P.;
- Parving, H.-H.
Publication type:
Article
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2009, v. 11, n. 10, p. 966, doi. 10.1111/j.1463-1326.2009.01079.x
By:
- Lund, S. S.;
- Tarnow, L.;
- Astrup, A. S.;
- Hovind, P.;
- Jacobsen, P. K.;
- Alibegovic, A. C.;
- Parving, I.;
- Pietraszek, L.;
- Frandsen, M.;
- Rossing, P.;
- Parving, H.-H.;
- Vaag, A. A.
Publication type:
Article
The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1.
Published in:
Diabetologia, 2013, v. 56, n. 8, p. 1845, doi. 10.1007/s00125-013-2919-8
By:
- Eupen, M.;
- Schram, M.;
- Colhoun, H.;
- Hanssen, N.;
- Niessen, H.;
- Tarnow, L.;
- Parving, H.;
- Rossing, P.;
- Stehouwer, C.;
- Schalkwijk, C.
Publication type:
Article
Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes.
Published in:
Diabetologia, 2013, v. 56, n. 2, p. 323, doi. 10.1007/s00125-012-2760-5
By:
- Alkayyali, S.;
- Lajer, M.;
- Deshmukh, H.;
- Ahlqvist, E.;
- Colhoun, H.;
- Isomaa, B.;
- Rossing, P.;
- Groop, L.;
- Lyssenko, V.
Publication type:
Article
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.
Published in:
Diabetologia, 2013, v. 56, n. 2, p. 259, doi. 10.1007/s00125-012-2755-2
By:
- Roscioni, S.;
- Zeeuw, D.;
- Hellemons, M.;
- Mischak, H.;
- Zürbig, P.;
- Bakker, S.;
- Gansevoort, R.;
- Reinhard, H.;
- Persson, F.;
- Lajer, M.;
- Rossing, P.;
- Heerspink, H.
Publication type:
Article
Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study.
Published in:
Diabetologia, 2013, v. 56, n. 1, p. 22, doi. 10.1007/s00125-012-2714-y
By:
- Hove, K.;
- Brøns, C.;
- Færch, K.;
- Lund, S.;
- Petersen, J.;
- Karlsen, A.;
- Rossing, P.;
- Rehfeld, J.;
- Vaag, A.
Publication type:
Article
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.
Published in:
Diabetologia, 2012, v. 55, n. 9, p. 2489, doi. 10.1007/s00125-012-2622-1
By:
- Nin, J.;
- Ferreira, I.;
- Schalkwijk, C.;
- Jorsal, A.;
- Prins, M.;
- Parving, H.-H.;
- Tarnow, L.;
- Rossing, P.;
- Stehouwer, C.
Publication type:
Article
A polymorphism in the gene encoding carnosinase ( CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.
Published in:
Diabetologia, 2010, v. 53, n. 12, p. 2562, doi. 10.1007/s00125-010-1863-0
By:
- Alkhalaf, A.;
- Bakker, S.;
- Bilo, H.;
- Gans, R.;
- Navis, G.;
- Postmus, D.;
- Forsblom, C.;
- Groop, P.;
- Vionnet, N.;
- Hadjadj, S.;
- Marre, M.;
- Parving, H.;
- Rossing, P.;
- Tarnow, L.
Publication type:
Article
Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes.
Published in:
Diabetologia, 2010, v. 53, n. 10, p. 2129, doi. 10.1007/s00125-010-1843-4
By:
- Reinhard, H.;
- Jacobsen, P.;
- Lajer, M.;
- Pedersen, N.;
- Billestrup, N.;
- Mandrup-Poulsen, T.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial.
Published in:
Diabetologia, 2010, v. 53, n. 8, p. 1576, doi. 10.1007/s00125-010-1789-6
By:
- Persson, F.;
- Rossing, P.;
- Reinhard, H.;
- Juhl, T.;
- Stehouwer, C.;
- Schalkwijk, C.;
- Danser, A.;
- Boomsma, F.;
- Frandsen, E.;
- Parving, H.-H.
Publication type:
Article
Telomere length predicts all-cause mortality in patients with type 1 diabetes.
Published in:
Diabetologia, 2010, v. 53, n. 1, p. 45, doi. 10.1007/s00125-009-1542-1
By:
- Astrup, A.;
- Tarnow, L.;
- Jorsal, A.;
- Lajer, M.;
- Nzietchueng, R.;
- Benetos, A.;
- Rossing, P.;
- Parving, H.-H.
Publication type:
Article
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study.
Published in:
Diabetic Medicine, 2021, v. 38, n. 9, p. 1, doi. 10.1111/dme.14405
By:
- Piazza, M.;
- Hanssen, N. M. J.;
- Persson, F.;
- Scheijen, J. L.;
- van de Waarenburg, M. P. H.;
- van Greevenbroek, M. M. J.;
- Rossing, P.;
- Hovind, P.;
- Stehouwer, C. D. A.;
- Parving, H‐H.;
- Schalkwijk, C. G.
Publication type:
Article
Hyperoxia improves autonomic function in individuals with long‐duration type 1 diabetes and macroalbuminuria.
Published in:
Diabetic Medicine, 2020, v. 37, n. 9, p. 1561, doi. 10.1111/dme.14315
By:
- Laursen, J. C.;
- Hansen, C. S.;
- Bordino, M.;
- Vistisen, D.;
- Zobel, E. H.;
- Winther, S. A.;
- Groop, P‐H.;
- Frimodt‐Møller, M.;
- Bernardi, L.;
- Rossing, P.
Publication type:
Article
Characteristics of high‐ and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.
Published in:
Diabetic Medicine, 2018, v. 35, n. 10, p. 1375, doi. 10.1111/dme.13669
By:
- Tofte, N.;
- Lindhardt, M.;
- Frimodt‐Møller, M.;
- Persson, F.;
- Rossing, P.;
- Dimos, I.;
- Francová, L.;
- Rychlík, I.;
- Girman, P.;
- Havrdova, T.;
- Göke, R.;
- Kooy, A.;
- Mischak, H.;
- Navis, G.;
- Nijpels, G.;
- Noutsou, M.;
- Ortiz, A.;
- Adamova, K.;
- Parvanova, A.;
- Ruggenenti, P. L.
Publication type:
Article
Cardiac repolarization and depolarization in people with Type 1 diabetes with normal ejection fraction and without known heart disease: a case‐control study.
Published in:
Diabetic Medicine, 2018, v. 35, n. 10, p. 1337, doi. 10.1111/dme.13689
By:
- Kanters, J. K.;
- Isaksen, J. L.;
- Graff, C.;
- Ellervik, C.;
- Jensen, J. S.;
- Jensen, M. T.;
- Rossing, P.
Publication type:
Article
Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes.
Published in:
Diabetic Medicine, 2018, v. 35, n. 11, p. 1596, doi. 10.1111/dme.13777
By:
- Hansen, C. S.;
- Theilade, S.;
- Lajer, M.;
- Hansen, T. W.;
- Rossing, P.
Publication type:
Article
The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes: a randomized clinical trial.
Published in:
Diabetic Medicine, 2018, v. 35, n. 3, p. 392, doi. 10.1111/dme.13577
By:
- Pilemann-Lyberg, S.;
- Persson, F.;
- Frystyk, J.;
- Rossing, P.
Publication type:
Article
Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus.
Published in:
Diabetic Medicine, 2016, v. 33, n. 12, p. 1625, doi. 10.1111/dme.13201
By:
- Jensen, T. M.;
- Vistisen, D.;
- Fleming, T.;
- Nawroth, P. P.;
- Rossing, P.;
- Jørgensen, M. E.;
- Lauritzen, T.;
- Sandbæk, A.;
- Witte, D. R.
Publication type:
Article
Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA<sub>1c</sub> compared with multiple daily injections: a longitudinal follow-up study.
Published in:
Diabetic Medicine, 2015, v. 32, n. 11, p. 1445, doi. 10.1111/dme.12950
By:
- Rosenlund, S.;
- Hansen, T. W.;
- Andersen, S.;
- Rossing, P.
Publication type:
Article
Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes.
Published in:
2015
By:
- Swan, E. J.;
- Salem, R. M.;
- Sandholm, N.;
- Tarnow, L.;
- Rossing, P.;
- Lajer, M.;
- Groop, P. H.;
- Maxwell, A. P.;
- McKnight, A. J.
Publication type:
Journal Article
Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes.
Published in:
Diabetic Medicine, 2015, v. 32, n. 8, p. 1104, doi. 10.1111/dme.12775
By:
- Swan, E. J.;
- Salem, R. M.;
- Sandholm, N.;
- Tarnow, L.;
- Rossing, P.;
- Lajer, M.;
- Groop, P. H.;
- Maxwell, A. P.;
- McKnight, A. J.
Publication type:
Article
Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
Published in:
Diabetic Medicine, 2015, v. 32, n. 3, p. 374, doi. 10.1111/dme.12606
By:
- Joergensen, C.;
- Tarnow, L.;
- Goetze, J. P.;
- Rossing, P.
Publication type:
Article
Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment.
Published in:
Diabetic Medicine, 2015, v. 32, n. 3, p. 343, doi. 10.1111/dme.12594
By:
- Scholten, B. J.;
- Lajer, M.;
- Goetze, J. P.;
- Persson, F.;
- Rossing, P.
Publication type:
Article
Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
Published in:
Diabetic Medicine, 2014, v. 31, n. 9, p. 1138, doi. 10.1111/dme.12447
By:
- Pena, M. J.;
- Lambers Heerspink, H. J.;
- Hellemons, M. E.;
- Friedrich, T.;
- Dallmann, G.;
- Lajer, M.;
- Bakker, S. J. L.;
- Gansevoort, R. T.;
- Rossing, P.;
- Zeeuw, D.;
- Roscioni, S. S.
Publication type:
Article
Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
Published in:
Diabetic Medicine, 2013, v. 30, n. 5, p. 563, doi. 10.1111/dme.12131
By:
- Andrésdóttir, G.;
- Bakker, S. J. L.;
- Hansen, H. P.;
- Parving, H.‐H.;
- Rossing, P.
Publication type:
Article
Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.
Published in:
Diabetic Medicine, 2012, v. 29, n. 8, p. 990, doi. 10.1111/j.1464-5491.2012.03633.x
By:
- Theilade, S.;
- Lajer, M.;
- Jorsal, A.;
- Tarnow, L.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.
Published in:
Diabetic Medicine, 2012, v. 29, n. 8, p. e184, doi. 10.1111/j.1464-5491.2012.03585.x
By:
- Nielsen, S. E.;
- Persson, F.;
- Frandsen, E.;
- Sugaya, T.;
- Hess, G.;
- Zdunek, D.;
- Shjoedt, K. J.;
- Parving, H-H.;
- Rossing, P.
Publication type:
Article
Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
Published in:
Diabetic Medicine, 2012, v. 29, n. 3, p. 337, doi. 10.1111/j.1464-5491.2011.03482.x
By:
- Theilade, S.;
- Lajer, M.;
- Jorsal, A.;
- Tarnow, L.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
Published in:
Diabetic Medicine, 2010, v. 27, n. 10, p. 1144, doi. 10.1111/j.1464-5491.2010.03083.x
By:
- Nielsen, S. E.;
- Schjoedt, K. J.;
- Astrup, A. S.;
- Tarnow, L.;
- Lajer, M.;
- Hansen, P. R.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow-up study.
Published in:
2007
By:
- Astrup AS;
- Tarnow L;
- Christiansen M;
- Hansen PR;
- Parving H;
- Rossing P
Publication type:
Journal Article
Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy—a prospective follow-up study.
Published in:
Diabetic Medicine, 2007, v. 24, n. 12, p. 1381, doi. 10.1111/j.1464-5491.2007.02283.x
By:
- Astrup, A. S.;
- Tarnow, L.;
- Christiansen, M.;
- Hansen, P. R.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Birth weight--a risk factor for progression in diabetic nephropathy?
Published in:
2003
By:
- Jacobsen, P.;
- Rossing, P.;
- Tarnow, L.;
- Hovind, P.;
- Parving, H-H.
Publication type:
journal article
Deconstructing Postracialism: Humor as a Critical, Cultural Project.
Published in:
2012
By:
- Rossing, Jonathan P.
Publication type:
Essay
Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled study.
Published in:
European Journal of Endocrinology, 2015, v. 172, n. 1, p. 11, doi. 10.1530/EJE-14-0554
By:
- Hove, K. D.;
- Brons, C.;
- Foerch, K.;
- Lund, S. S.;
- Rossing, P.;
- Vaag, A.
Publication type:
Article
iLearning: The future of higher education? Student perceptions on learning with mobile tablets.
Published in:
Journal of the Scholarship of Teaching & Learning, 2012, v. 12, n. 2, p. 1
By:
- Rossing, Jonathan P.;
- Miller, Willie M.;
- Cecil, Amanda K.;
- Stamper, Suzan E.
Publication type:
Article
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
Published in:
Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0539-1
By:
- Peeters, S. A.;
- Engelen, L.;
- Buijs, J.;
- Jorsal, A.;
- Parving, H.-H.;
- Tarnow, L.;
- Rossing, P.;
- Schalkwijk, C. G.;
- Stehouwer, C. D. A.
Publication type:
Article
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus.
Published in:
Diabetic Medicine, 2001, v. 18, n. 3, p. 199, doi. 10.1046/j.1464-5491.2001.00446.x
By:
- Rossing, P.;
- Breum, L.;
- Major-Pedersen, A.;
- Sato, A.;
- Windling, H.;
- Pietersen, A.;
- Kastrup, J.;
- Parving, H.-H.
Publication type:
Article
Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy.
Published in:
Diabetic Medicine, 1999, v. 16, n. 7, p. 555, doi. 10.1046/j.1464-5491.1999.00127.x
By:
- Nielsen, F. S.;
- Hansen, H. P.;
- Jacobsen, P.;
- Rossing, P.;
- Smidt, U. M.;
- Christensen, N. J.;
- Pevet, P.;
- Vivien-Roels, B.;
- Parving, H. -H.
Publication type:
Article
Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy.
Published in:
Diabetic Medicine, 1999, v. 16, n. 5, p. 388, doi. 10.1046/j.1464-5491.1999.00063.x
By:
- Christensen, P. K.;
- Rossing, P.;
- Nielsen, F. S.;
- Parving, H. -H.
Publication type:
Article
Promotion, prediction and prevention of progression of nephropathy in Type 1 diabetes mellitus.
Published in:
Diabetic Medicine, 1998, v. 15, n. 11, p. 900, doi. 10.1002/(SICI)1096-9136(1998110)15:11<900::AID-DIA709>3.0.CO;2-0
By:
- Rossing, P
Publication type:
Article
Left Ventricular Hypertrophy in Non-insulin-dependent Diabetic Patients With and Without Diabetic Nephropathy.
Published in:
Diabetic Medicine, 1997, v. 14, n. 7, p. 538, doi. 10.1002/(SICI)1096-9136(199707)14:7<538::AID-DIA415>3.0.CO;2-I
By:
- Nielsen, F.S;
- Ali, S.;
- Rossing, P.;
- Bang, L.E.;
- Svendsen, T.L.;
- Gall, M.-A.;
- Smidt, U.M.;
- Kastrup, J.;
- Parving, H.-H.
Publication type:
Article

Found: 86